Clinical Trial Update: T Cell Receptor Gene Therapy Targeting KK-LC-1 for Gastric, Breast, Cervical, Lung and Other KK-LC-1 Positive Epithelial Cancers [Phase 1]

View source ↗

Summary

Phase 1 trial of KK-LC-1 targeted T cell receptor gene therapy across KK-LC-1 positive gastric, breast, cervical, and lung cancers; the study has been terminate…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Cervical Cancer
• Gastric Cancer
• Lung Cancer

Drugs mentioned

• KK-LC-1 targeted T cell receptor gene therapy

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Kita-kyushu Lung Cancer Antigen 1, Human | Phase 1 | Status: TERMINATED | Results posted: 2025-12-02